Smart molecules for Neurodegenerative and Rare disorders

THE PROJECT

MIRAMOON pharma
 is a drug discovery spin-off

Coming from Biodonostia Health Research Institute and University of the Basque Country, the company aim is to develop new drugs “First in Class” based on the interaction with new protein receptor that modulates the ryanodine calcium channel.

MIRAMOON pharma
 is a drug discovery spin-off

Comming from Biodonostia Health Research Institute and University of the Basque Country, the company aim is to develop new drugs “First in Class” based on the interaction with new protein receptor that modulates the ryanodine calcium channel.

This target is totally new and its modulation opens the door to the development of drugs with a new mechanism of action that can treat a series of diseases that are currently intractable. 

OUR TECHNOLOGY

A family of molecules patented with therapeutic potential for a number of neurodegenerative diseases that have in common a change in intracellular calcium flows.

logo-bl-300

Applications for:

DUCHENNE

ELA

ALZHEIMER

...

ADVANTAGES

Topical administration

Able to reach the retina without coming into contact with the rest of the general metabolism.

THE TEAM

Company

The company is headed by a first-rate team with experience in drug development, neuromuscular diseases, venture capital and licensing.

Advisors

Our advisors are renowned scientists in the world of medical chemistry and entrepreneurs with a long history working and advising the main players in pharmaceutical companies.

“First-rate team with experience in drug development which will ensure an efficient management”

logo-bl-300

“First-rate team with experience in drug development which will ensure an efficient management”

Company

The company is headed by a first-rate team with experience in drug development, neuromuscular diseases, venture capital and licensing.

Advisors

Our advisors are renowned scientists in the world of medical chemistry and entrepreneurs with a long history working and advising the main players in pharmaceutical companies.

CONTACTS



    Edificio Korta

    Av. Tolosa 72
    20018 y Donostia/ San Sebastián
    Spain

    This website uses cookies to remember users and understand ways to enhance their experience.    More info
    Privacidad